Table 3 HCP ovarian cancer and genetics knowledge (n = 146)
Total (n = 146) | GP (n = 32) | Genetics (n = 44) | Oncologists (n = 45) | Gynaecology (n = 15) | Nurse & other (n = 10) | |
|---|---|---|---|---|---|---|
Correctly answered, N (%) | ||||||
A smear test is not designed to detect ovarian cancer (True) | 143 (97.9) | 32 (100.0) | 43 (97.7) | 44 (97.8) | 15 (100) | 9 (90.0) |
Taking the contraceptive pill can increase a woman’s risk of developing ovarian cancer (False) | 134 (91.8) | 24 (75.0) | 43 (97.7) | 42 (93.3) | 15 (100) | 10 (100.0) |
The majority of cases of ovarian cancer are caused by an inherited genetic mutation (False) | 123 (84.2) | 13 (40.6) | 43 (97.7) | 44 (97.8) | 15 (100) | 8 (80.0) |
Paternal family history of cancer is as important as maternal family history of cancer when considering a patient’s risk of ovarian cancer (True) | 108 (74.0) | 10 (31.3) | 42 (95.5) | 37 (82.2) | 10 (66.7) | 9 (90.0) |
A genetic test result that shows a patient has a variant of uncertain significance (VUS) indicates that the patient does not have an increased risk for ovarian cancer (False) | 111 (76.0) | 15 (46.9) | 41 (93.2) | 32 (71.1) | 13 (86.7) | 10 (100.0) |
The average risk of a women developing ovarian cancer in her lifetime is approximately (2%) | 115 (78.8) | 13 (40.6) | 44 (100) | 37 (82.2) | 14 (93.3) | 7 (70.0) |
The risk of a woman with a BRCA1 mutation developing ovarian cancer in her lifetime is approximately (30–60%) | 102 (69.9) | 13 (40.6) | 40 (90.9) | 32 (71.1) | 11 (73.3) | 6 (60.0) |
The risk of a woman with a BRCA2 mutation developing ovarian cancer in her lifetime is approximately (10–30%) | 91 (62.3) | 8 (25.0) | 36 (81.8) | 29 (64.4) | 10 (66.7) | 8 (80.0) |